|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 62 studies with search of: | brainstem glioma | Open Studies |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
|
||||
| 2 | Recruiting |
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
|
||||
| 3 | Recruiting |
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
|
||||
| 4 | Recruiting |
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
|
||||
| 5 | Recruiting |
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
|
||||
| 6 | Recruiting |
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
|
||||
| 7 | Recruiting |
Vaccine Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
|
||||
| 8 | Recruiting |
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
||||
| 9 | Not yet recruiting |
Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
|
||||
| 10 | Recruiting |
Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health
|
||||
| 11 | Recruiting |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
||||
| 12 | Recruiting |
Study of Patients With Cancer or Precancerous Conditions
|
||||
| 13 | Recruiting |
Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
|
||||
| 14 | Recruiting |
Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors
|
||||
| 15 | Recruiting |
Proton Nuclear Magnetic Resonance Spectroscopic Imaging Compared With Fludeoxyglucose F 18 Positron Emission Tomography Scanning in Determining Biologic or Metabolic Tumor Activity in Young Patients With Brain Tumors
|
||||
| 16 | Recruiting |
Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade Glioma
|
||||
| 17 | Recruiting |
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
|
||||
| 18 | Recruiting |
Study of Late-Occurring Complications in Childhood Cancer Survivors
|
||||
| 19 | Recruiting |
Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinical Trial
|
||||
| 20 | Recruiting |
Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|